As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers
The FDA has granted Priority Review, setting a target decision date of 9 October 2026, potentially accelerating access to a new treatment option for a subset of patients with high-risk colon cancer characterized
The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
